PCT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
PCT is not a good buy right now. With no Intellectia buy signals, weakening technicals (bearish MACD), downside-biased pattern projections (next week/month negative), heavy hedge-fund selling, and an analyst downgrade with a $9 target below the current ~$10.1 pre-market price, the near-term risk/reward skews downward for an impatient buyer.
Price/Trend (pre-market ~$10.10, -1.17%): The stock is trading below the key pivot (11.244) and is sitting near support (S1 10.388; S2 9.86). A break/hold below ~10.39 increases the odds of a move toward ~9.86. Momentum: MACD histogram is negative (-0.0473) and expanding lower, signaling bearish momentum is strengthening. RSI(6) ~32 is near oversold but not showing a confirmed reversal; it can stay weak while price drifts lower. Moving Averages: Converging MAs suggest no established uptrend; combined with bearish MACD, this typically aligns with chop-to-down bias. Pattern-based expectation: Similar-pattern stats imply modest downside probabilities (next day -0.13%, next week -0.97%, next month -2.07%).
Intellectia Proprietary Trading Signals
can support a short-term bounce if support near ~10.39 holds.
indicates some market participants are positioned for upside over time.
caps upside unless reclaimed.
Latest reported quarter: 2025/Q3. Revenue was ~$2.43M (flat YoY), indicating growth has not yet materialized at the top line. Losses deepened materially: Net income fell to -$28.37M (down ~68.7% YoY) and EPS to -$0.16 (down ~70.37% YoY). Overall, the quarter shows weak growth with worsening profitability trends.
Recent trend: TD Cowen downgraded PCT to Hold from Buy (2025-11-24) and cut the price target to $9 from $16, explicitly citing order delays and assumed delays to the growth plan. Wall Street pros vs cons: Pros—if the company executes, the value proposition could re-rate and call-heavy OI suggests some investors still expect upside. Cons—near-term execution risk (delays), no profitability yet, worsening losses, and the reduced target below the current price argues limited upside and higher downside risk in the near term. Influential/political activity: No recent congress trading data available; insider activity is neutral.
